Publications by authors named "H Eraksoy"

Article Synopsis
  • The study aimed to address the lack of research on pneumonia management in immunocompromised patients, focusing on their specific unmet needs.
  • An observational study of 140 CAP patients indicated a 30-day mortality rate of 17.8%, with higher fatalities noted in patients with Pseudomonas aeruginosa and in those who did not respond to treatment within three days.
  • The findings suggest that early treatment response is crucial for improving outcomes in immunocompromised patients, highlighting a significant area that needs more attention in clinical care.
View Article and Find Full Text PDF
Article Synopsis
  • Cardiovascular disease (CVD) significantly affects people living with HIV (PLWH), with this study finding a diagnosed CVD prevalence of 10.8% among 1425 participants aged 40-75.
  • The assessment utilized five different risk evaluation tools, revealing that 42.8% of participants had a high 10-year risk of CVD, while 71.7% were classified as high- to very high-risk using the SCORE2 tool.
  • The findings stress the need for better cardiovascular health monitoring and highlighted that current utilization of lipid-lowering therapy is inadequate, despite a large number of PLWH being eligible for such treatment per recent guidelines.
View Article and Find Full Text PDF

Background: To the best of our knowledge, this is the first study to evaluate the effectiveness of specific concentrations of antibiofilm agents, such as N-acetyl cysteine (NAC), rifampicin, and ozone, for the treatment of pan-resistant Klebsiella pneumoniae (PRKp).

Objectives: We evaluated the effectiveness of antibiofilm agents, such as NAC, rifampicin, and ozone, on biofilm formation in PRKp at 2, 6, 24, and 72 h.

Design And Setting: This single-center experimental study was conducted on June 15, 2017, and July 15, 2018, at Istanbul Faculty of Medicine, Istanbul University, Turkey.

View Article and Find Full Text PDF

Human pegivirus (HPgV) is transmitted through sexual or parenteral exposure and is common among patients receiving blood products. HPgV is associated with lower levels of human immunodeficiency virus (HIV) RNA and better survival among HIV-infected patients. This study aimed to investigate the prevalence of HPgV and determine its subtypes in HIV-infected individuals living in Istanbul, which has the highest rate of HIV infection in Türkiye.

View Article and Find Full Text PDF